Showing 6,361 - 6,380 results of 26,761 for search '(( significant ((treatment decreased) OR (teer decrease)) ) OR ( significant linear decrease ))*', query time: 0.82s Refine Results
  1. 6361

    Table_1_IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment.pdf by Elisa Toppi (12099965)

    Published 2022
    “…Here we report that MCI patients supplemented with homotaurine for 12 months show elevated serum levels of IL-10 and IL-33, as compared to baseline, in addition to the described IL-18 decrease. Furthermore, we observed a significant positive correlation between IL-10 and IL-33 levels after treatment but not at the baseline, underlining the effectiveness of the compound in modulating both cytokines in an inter-related fashion and in regulating the pro/anti-inflammation balance. …”
  2. 6362

    Results of the LMM analysis for IOP change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…The preoperative IOP was 15.06 ± 3.51 mmHg and significantly reduced to 12.22 ± 2.23 mmHg at 3 months and 12.99 ± 2.45 mmHg at 12 months. …”
  3. 6363

    Results of the LMM analysis for GMS change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…The preoperative IOP was 15.06 ± 3.51 mmHg and significantly reduced to 12.22 ± 2.23 mmHg at 3 months and 12.99 ± 2.45 mmHg at 12 months. …”
  4. 6364

    TBI is ESKD. by Belinda L. Baines (18446381)

    Published 2024
    “…Comparison of values for each patient were tested for differences using paired t-tests. Linear mixed-effects models were used to test for the effect of patient and clinical factors on change in outcome measures.…”
  5. 6365

    Data_Sheet_1_Dietary ω-3 intake for the treatment of morning headache: A randomized controlled trial.docx by Marco Marchetti (660958)

    Published 2022
    “…During dietary treatment, group A progressively dismissed ketoprofen-based pharmacological treatment (p = 0.002) from baseline to t1. …”
  6. 6366

    Data_Sheet_2_Dietary ω-3 intake for the treatment of morning headache: A randomized controlled trial.docx by Marco Marchetti (660958)

    Published 2022
    “…During dietary treatment, group A progressively dismissed ketoprofen-based pharmacological treatment (p = 0.002) from baseline to t1. …”
  7. 6367

    Evaluation of High-Dose Vitamin A Treatment in Postmolar Patients with Low and Plateauing Serum Human Chorionic Gonadotropin Levels by Elza Maria Hartmann Uberti (10459809)

    Published 2021
    “…Conclusion The limited use of HD Vit-A seems to have a safe and significant effect on the treatment of postmolar patients with L&P serum hCG levels and may decrease the development of postmolar GTN in this population.…”
  8. 6368
  9. 6369

    DataSheet1_Network meta-analysis of integrated traditional Chinese and Western medicine in the treatment of Sjogren’s syndrome.pdf by Xieli Ma (20153298)

    Published 2024
    “…</p>Conclusion<p>TCM combined with CWM has a very significant effect on treating SS compared with CWM alone. …”
  10. 6370

    Treatment outcomes of pulp revascularization in traumatized immature teeth using calcium hydroxide and 2% chlorhexidine gel as intracanal medication by Andrea Cardoso PEREIRA (6299792)

    Published 2021
    “…MTA placement from the apex and age at the time of treatment was not significantly associated with the quantitative radiographic outcomes. …”
  11. 6371

    Supplementary Material for: Angiopausin® and Angiopoietin: Unveiling New Mechanisms in Rosacea Treatment through Kinetic Erythema Analysis with the AAREA® Algorithm by figshare admin karger (2628495)

    Published 2025
    “…It also highlighted how advances in rosacea therapy can be studied by profiling the clinical effects of treatments using artificial intelligence. The AAREA tool provided valuable data for clinical scoring and research into understanding rosacea pathogenesis.…”
  12. 6372

    Table_1_Impact of changing treatment strategy based on circulating tumor cells on postoperative survival of breast cancer.xls by Zihan Wang (3129810)

    Published 2022
    “…By changing the treatment strategy, CTC-positive patients achieved DFS that was not significantly different from CTC-negative patients (95.0% vs. 97.7%, 77.5% vs. 82.9%, 57.6% vs. 59.9%, p=0.20).…”
  13. 6373

    DataSheet_1_Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy.docx by Doris N. Rusu (17624388)

    Published 2023
    “…Compared to the scheduled plan, the post-treatment plans showed a decrease in the V33Gy, demonstrating the benefit of plan adaptation for 66% of the fractions for the duodenum, 95% for the stomach, 100% for the colon, and 79% for the small bowel.…”
  14. 6374

    Supporting data for “Androgen receptor modulates chemotherapy response in breast cancer” by Chanping You (9067448)

    Published 2025
    “…Chemotherapies, encompassing both systemic and targeted approaches, are critical for managing the disease, yet drug resistance often compromises treatment efficacy. The androgen receptor (AR), a widely expressed hormonal receptor in breast cancer, has an unclear role in disease progression. …”
  15. 6375

    Image_1_Efficacy and Safety of NaoShuanTong Capsule in the Treatment of Ischemic Stroke: A Meta-Analysis.pdf by Hanlai Zhang (7486838)

    Published 2019
    “…However, there was no significant difference between NSTC treatment and conventional therapy with respect to Fugl-Meyer Assessment score (MD = 10.59, 95% CI [-1.78, 22.96], P = 0.09) or Crouse score (MD = -0.78, 95% CI [-1.79, -0.22], P = 0.13).…”
  16. 6376

    DataSheet_1_Identifying hub genes in response to ustekinumab and the impact of ustekinumab treatment on fibrosis in Crohn’s disease.zip by Ying Xu (9172)

    Published 2024
    “…IL18, the ligand of IL18R1, was also found to have lower expression in the blood samples from responders vs. non-responders. (2) GSE112366 revealed a significant decrease in fibrosis-related module genes (COL4A1, TUBB6, IFITM2, SERPING1, DRAM1, NAMPT, MMP1, ZEB2, ICAM1, PFKFB3, and ACTA2) and fibrosis-related pathways (ECM–receptor interaction and PI3K-AKT pathways) after ustekinumab treatment.…”
  17. 6377

    Nilotinib treatment of Mtb-infected mice activates lysosome functions of lung myeloid subsets and reduces lung bacterial burdens. by Weihao Zheng (767955)

    Published 2024
    “…At 28 dpi, mice were euthanized, and lungs were harvested for analysis. (B-C) Nilotinib treatment of mice (B) decreases overall Mtb lung bacterial burdens and (C) reduces infected lung myeloid cells in treated mice (28 dpi). …”
  18. 6378

    <b> </b> Spatial memory assessment in Morris water maze test. 5A: Effect of different treatments on time spent in the target zone. Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01).... by Atefeh Sadeghi (21253051)

    Published 2025
    “…<p><b> </b> Spatial memory assessment in Morris water maze test. 5A: Effect of different treatments on time spent in the target zone. Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01). …”
  19. 6379

    Image 1_Atractylenolide-I prevents abdominal aortic aneurysm formation through inhibiting inflammation.tif by Shuxiao Chen (7339340)

    Published 2025
    “…</p>Conclusions<p>ATL-I meliorated vascular inflammation by targeting AMPK signaling, ultimately inhibiting AAA formation, which provided an alternative agent for AAA treatment.</p>…”
  20. 6380